198 related articles for article (PubMed ID: 10471756)
1. Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil.
Waiser J; Budde K; Braasch E; Neumayer HH
Am J Kidney Dis; 1999 Sep; 34(3):e9. PubMed ID: 10471756
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
[TBL] [Abstract][Full Text] [Related]
3. Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitis.
Haubitz M; de Groot K
Clin Nephrol; 2002 Jun; 57(6):421-4. PubMed ID: 12078944
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial.
Tuin J; Stassen PM; Bogdan DI; Broekroelofs J; van Paassen P; Cohen Tervaert JW; Sanders JS; Stegeman CA
Clin J Am Soc Nephrol; 2019 Jul; 14(7):1021-1028. PubMed ID: 31253599
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil in the treatment of ocular inflammation in ANCA-associated vasculitis.
Yalçindağ FN; Amer R; Forrester JV
J Ocul Pharmacol Ther; 2008 Apr; 24(2):249-54. PubMed ID: 18321200
[TBL] [Abstract][Full Text] [Related]
6. Successful renal transplantation in a patient with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis: effect of early plasma exchange and mycophenolate mofetil.
Sun Q; Cheng D; Wen J; Chen J; Gong D; Liu Z; Li L
Transplant Proc; 2008 Dec; 40(10):3764-6. PubMed ID: 19100484
[TBL] [Abstract][Full Text] [Related]
7. Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide.
Stassen PM; Tervaert JW; Stegeman CA
Ann Rheum Dis; 2007 Jun; 66(6):798-802. PubMed ID: 17179175
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients.
Wendt M; Gunnarsson I; Bratt J; Bruchfeld A
Scand J Rheumatol; 2012 Mar; 41(2):116-9. PubMed ID: 22118245
[TBL] [Abstract][Full Text] [Related]
9. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement.
Iatrou C; Zerbala S; Revela I; Spanou E; Marinaki S; Nakopoulou L; Boletis J
Clin Nephrol; 2009 Jul; 72(1):31-7. PubMed ID: 19640385
[TBL] [Abstract][Full Text] [Related]
11. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil in systemic vasculitis.
D'Cruz DP
Lupus; 2005; 14 Suppl 1():s55-7. PubMed ID: 15803934
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity.
Ibernon M; Poveda R; Vidaller A; Bestard O; Grinyó JM
Clin Nephrol; 2008 Jun; 69(6):395-401. PubMed ID: 18538114
[TBL] [Abstract][Full Text] [Related]
14. Acute hepatitis following mycophenolate mofetil administration for ANCA-positive vasculitis.
Dourakis SP; Boki K; Soultati A; Cherouvim E; Delladetsima I
Scand J Rheumatol; 2007; 36(3):237-9. PubMed ID: 17657683
[No Abstract] [Full Text] [Related]
15. Use of mycophenolate in ANCA-associated renal vasculitis: 13 years of experience at a university hospital.
Draibe J; Poveda R; Fulladosa X; Vidaller A; Zulberti C; Gomà M; Pujol R; Ripoll È; Torras J; Grinyó JM
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i132-7. PubMed ID: 25805744
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.
Silva F; Specks U; Kalra S; Hogan MC; Leung N; Sethi S; Fervenza FC
Clin J Am Soc Nephrol; 2010 Mar; 5(3):445-53. PubMed ID: 20093349
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
Koukoulaki M; Jayne DR
Nephron Clin Pract; 2006; 102(3-4):c100-7. PubMed ID: 16286784
[TBL] [Abstract][Full Text] [Related]
18. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.
Hogan SL; Falk RJ; Chin H; Cai J; Jennette CE; Jennette JC; Nachman PH
Ann Intern Med; 2005 Nov; 143(9):621-31. PubMed ID: 16263884
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.
Jones RB; Hiemstra TF; Ballarin J; Blockmans DE; Brogan P; Bruchfeld A; Cid MC; Dahlsveen K; de Zoysa J; Espigol-Frigolé G; Lanyon P; Peh CA; Tesar V; Vaglio A; Walsh M; Walsh D; Walters G; Harper L; Jayne D;
Ann Rheum Dis; 2019 Mar; 78(3):399-405. PubMed ID: 30612116
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.
Stangou M; Asimaki A; Bamichas G; Christidou F; Zoumbaridis N; Natse T; Galanis N; Christaki P; Patakas D; Sombolos K
J Nephrol; 2005; 18(1):35-44. PubMed ID: 15772921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
